Skip to main content

Table 2 Demographic and clinical features of the patients included in the study: Serum samples

From: Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

  Disease Number of patients Age (Mean ± SD) Gender
Validation RRMS 56 35.5 ± 11.2 14M; 42F
INF 53 46.7 ± 16.1 17M; 36F
N-INF 58 51.3 ± 12.7 23M; 35F
  1. M male, F female, RRMS Relapse–remitting multiple sclerosis, INF other inflammatory diseases of the CNS, N-INF non-inflammatory diseases of the CNS